Skip to main content

Updates to three midwifery standards to reflect expanded scope


Sep 14, 2026

The BCCNM board on Sept. 11, 2026, approved updates to three midwifery practice standards to reflect recent changes to the Nurses and Midwives Regulation. The revised standards take effect immediately and support safe implementation of expanded midwifery scope, including the use of devices for induction and augmentation of labour; expanded use of ultrasound; prescribing for lactation suppression, hypothyroidism, first-trimester medical abortion; and medication management of early pregnancy loss.

The updated standards are:

S​ummary of changes

The amended standards clarify when midwives must complete additional education and when existing certification or prescribing requirements continue to apply. The requirements are based on the complexity and risk of each activity and are intended to support safe, competent, and person-centred care.

Additional education is a board-approved regulatory term already used in BCCNM nursing standards. It means structured education—such as a workshop, course, or program of study—that builds on entry-level competencies and includes theory, application to practice, and an evaluation of competence. BCCNM is developing a resource to help midwives understand this requirement, which will be shared in an upcoming newsletter.

  • Certified Midwives: Induction and Augmentation of Labour​: Updates include the use of devices for induction and augmentation of labour within the existing certification framework. The amended standard clarifies expectations when a midwife uses a devi​ce or uterotonic agent, updates criteria previously set out in the limits and conditions and keeps the requirement to consult with a physician when induction or augmentation is considered for a client with a previous caesarean section or uterine surgery.

  • Midwives: Screening and Diagnostic Tests and Imaging: Updates include additional education requirements for midwives who use ultrasound for purposes beyond fetal heart monitoring and determining fetal position. The amendments also clarify that point-of-care ultrasoun​d does not replace comprehensive diagnostic imaging when it is clinically indicated. Additional education options are available through UBC Continuing Professional Development and other Canadian providers.

  • Midwives: Medications and Substances: Updates include new prescribing authorities for lactation suppression, hypothyroidism, first-trimester medical abortion, and medication management of early pregnancy loss. Existing prescribing requirements continue to apply to lactati​​on suppression, while additional education is required for the other areas.

With the approval of these scope expansions, additional education will support midwives in acquiring the knowledge and competencies required for implementation, including:

  • Medical abortion and early pregnancy loss care

    • The Society of Obstetricians and Gynaecologists of Canada (SOGC) offers Medical Abortion Through Primary Care.
  • Use of ultrasound for midwifery purposes

    • UBC Continuing Professional Development (UBC CPD) offers Hands-On Ultrasound Education Obstetrics (HOUSE OB), which supports the development of competencies in point-of-care obstetrical ultrasound.
  • Management of hypothyroidism in pregnancy

    • A course on hypothyroidism management for midwives is being developed by UBC Continuing Professional Development (UBC CPD) and is anticipated to be available in early 2027.

​​Midwives are responsible for ensuring that any education undertaken meets the definition of additional education set out in the BCCNM bylaws and is sufficient to support safe and competent practice within the expanded scope.

Questions a​bout the updated standards?

Contact our Standards Support team.

900 – 200 Granville St.
Vancouver, BC  V6C 1S4
Canada

info@bccnm​.ca
604.742.6200​
​Toll-free 1.866.880.7101 (within Canada only) ​


We acknowledge the rights and title of the First Nations on whose collective unceded territories encompass the land base colonially known as British Columbia. We give specific thanks to the hən̓q̓əmin̓əm̓ speaking peoples the xʷməθkʷəy̓əm (Musqueam) and sel̓íl̓witulh (Tsleil-Waututh) Nations and the Sḵwx̱wú7mesh-ulh Sníchim speaking Peoples the Sḵwx̱wú7mesh Úxwumixw (Squamish Nation), on whose unceded territories BCCNM’s office is located. We also give thanks for the medicines of these territories and recognize that laws, governance, and health systems tied to these lands and waters have existed here for over 9000 years.

We also acknowledge the unique and distinct rights, including rights to health and wellness, of First Nations, Inuit​ and Métis peoples from elsewhere in Canada who now live in British Columbia. As leaders in the settler health system, we acknowledge our responsibilities to these rights under international, national, and provincial law.​